header logo image

Thomas Vincent Johnson III, M.D., Ph.D. – Johns Hopkins Medicine

October 16th, 2023 8:24 pm

Lab

Lab Website: Johnson Laboratory

View all on PubMed

Johnson TV, Martin KR. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3503-12. doi: 10.1167/iovs.07-1601. Epub 2008 Apr 11. PubMed PMID: 18408186.

Johnson TV, Oglesby EN, Steinhart MR, Cone-Kimball E, Jefferys J, Quigley HA. Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant Culture. Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):253-64. doi: 10.1167/iovs.15-17769. PubMed PMID: 26811145; PubMed Central PMCID: PMC4736988.

Johnson TV, DeKorver NW, Levasseur VA, Osborne A, Tassoni A, Lorber B, Heller JP, Villasmil R, Bull ND, Martin KR, Tomarev SI. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome. Brain. 2014 Feb;137(Pt 2):503-19. doi: 10.1093/brain/awt292. Epub 2013 Oct 30. PubMed PMID: 24176979; PubMed Central PMCID: PMC3914467.

Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, Martin KR. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2051-9. doi: 10.1167/iovs.09-4509. Epub 2009 Nov 20. PubMed PMID: 19933193; PubMed Central PMCID: PMC2868400.

Johnson TV, Bull ND, Martin KR. Identification of barriers to retinal engraftment of transplanted stem cells.Invest Ophthalmol Vis Sci. 2010 Feb;51(2):960-70. doi: 10.1167/iovs.09-3884. Epub 2009 Oct 22. PubMed PMID: 19850833; PubMed Central PMCID: PMC2868445.

Read the original post:
Thomas Vincent Johnson III, M.D., Ph.D. - Johns Hopkins Medicine

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick